Research now demonstrates that apolipoprotein B and non‐HDL cholesterol more accurately reflect atherogenic lipoprotein burden than LDL cholesterol alone, while the triglyceride‐to‐HDL cholesterol ratio is a useful marker of insulin resistance and metabolic dysfunction. The gene discussed is APOB; the disease is Insulin resistance.